141 studies found for:    niaid hiv/aids | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Gene Expression in HIV and Tuberculosis Co-infection
Conditions: Tuberculosis;   HIV;   IRIS
Intervention:
22 Recruiting HIV Accelerated Liver Disease in Uganda
Condition: Fibrosis
Intervention:
23 Recruiting Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma
Conditions: Immunodeficiency;   Mycobacterial Infection;   Opportunistic Infection
Intervention:
24 Recruiting VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...
Conditions: HIV-1 Infection;   Neutralizing Antibody;   Monoclonal Antibody;   Viral Load;   HIV Antibodies
Intervention: Drug: VRC-HIVMAB060-00-AB
25 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
26 Recruiting Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients
Condition: HIV Infections
Intervention:
27 Recruiting Studies of Blood and Reproductive Fluids in HIV-Infected and Non-HIV-Infected Persons
Condition: HIV Infection
Intervention:
28 Recruiting Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals
Conditions: HIV Infection;   Viremia
Intervention:
29 Recruiting Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults
Conditions: HIV Infection;   Monoclonal Antibody, Human;   HIV Antibodies;   VRC01 Monoclonal Antibody;   Neutralizing Antibody
Intervention: Drug: VRC-HIVMAB060-00-AB
30 Recruiting Clinical Outcomes in Persons With HIV Acquired Early in Life
Conditions: HIV;   Childhood;   Natural History;   Cardiac;   ART
Intervention:
31 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
32 Recruiting Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Condition: Immunodeficiency Virus, Human
Interventions: Drug: Aspirin 81 mg table;   Drug: Atorvastatin 40 mg
33 Recruiting Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV
Conditions: Hepatitis C, Chronic;   Co-Infection
Intervention: Drug: Fixed Dose GS-7997 / GS-5885
34 Recruiting Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda
Condition: Malaria
Intervention: Drug: TMP-SMX
35 Recruiting Leukapheresis for Research on HCV-Coinfected Patients
Conditions: Hepatitis C;   HIV Infections
Intervention:
36 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Conditions: HIV;   Atrial Fibrillation;   Venous Thromboembolism
Interventions: Drug: Ritonavir;   Drug: Cobicistat
37 Not yet recruiting The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial
Condition: Rapid HIV Screening
Interventions: Other: A: Nontargeted rapid HIV screening;   Other: B: Enhanced targeted rapid HIV screening;   Other: C: Traditional targeted rapid HIV screening
38 Not yet recruiting Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX
39 Not yet recruiting Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123;   Biological: NYVAC-HIV-PT1;   Biological: NYVAC-HIV-PT4;   Biological: AIDSVAX B/E®;   Biological: Placebo vaccine
40 Recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years